table
Return to article

Мониторинг фармакодинамики Апиксабана у пациентов с фибрилляцией предсердий неклапанной этиологии

Figure 1 - Confidence intervals of 3-day monitoring of apixaban concentration at a dose of 5 mg twice daily in the blood plasma of patients with AFNE

Confidence intervals of 3-day monitoring of apixaban concentration at a dose of 5 mg twice daily in the blood plasma of patients with AFNE